Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Killer Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03213964
What this trial is testing

Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Masonic Cancer Center, University of Minnesota 10
Early research (Phase 1)UnknownNCT04221971
What this trial is testing

NK Cell Infusion for Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Peking University People's Hospital 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07457177
What this trial is testing

Phaes Ⅱ Study of Golidocitinib-Pegaspargase-PD-1 Antibody First-Line for Advanced ENKTL

Who this might be right for
NK T-Cell Lymphoma
LIANG WANG 40
Not applicableStudy completedNCT02019628
What this trial is testing

Enhanced Natural Killer Cell Activity and RBAC

Who this might be right for
Family Member
University of Miami 20
Testing effectiveness (Phase 2)Study completedNCT03007823
What this trial is testing

High-activity Natural Killer Immunotherapy for Small Metastases of Melanoma

Who this might be right for
Melanoma
Fuda Cancer Hospital, Guangzhou 20
Not applicableLooking for participantsNCT06848582
What this trial is testing

Umbilical Cord Blood NK Cell Therapy for High-Risk Pediatric Soft Tissue Sarcoma: Efficacy and Safety Study

Who this might be right for
Soft Tissue Sarcoma (STS)
Sun Yat-sen University 40
Early research (Phase 1)Temporarily pausedNCT00909558
What this trial is testing

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

Who this might be right for
Breast CancerGliomaHepatocellular Cancer+4 more
Envita Medical Center, Inc. 24
Not applicableStudy completedNCT02525250
What this trial is testing

Pilot Study Immunomonitoring Natural Killers Cells in Patients With Myeloid Malignancies Treated With Lenalidomide

Who this might be right for
Acute Myeloid Leukemia or Myelodysplasic Syndrome
Institut Paoli-Calmettes 14
Testing effectiveness (Phase 2)UnknownNCT03598959
What this trial is testing

Tofacitinib Combined With Chidamide in R/R ENKTCL

Who this might be right for
Extranodal NK/T-cell Lymphoma
Sichuan University 20
Early research (Phase 1)UnknownNCT06027853
What this trial is testing

Natural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid Leukemia

Who this might be right for
AML, Adult
Zhejiang University 24
Early research (Phase 1)Active Not RecruitingNCT02573896
What this trial is testing

Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 13
Not applicableActive Not RecruitingNCT05315388
What this trial is testing

Effects of "Vitamin N" Nature Immersion Therapy on Stress Levels in Health Care Workers in the City of Bogotá

Who this might be right for
Cortisol ExcessStress, PsychologicalAnxiety+3 more
Jeadran N. Malagón-Rojas 118
Testing effectiveness (Phase 2)Looking for participantsNCT06967038
What this trial is testing

Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients With Primary Sjogren's Syndrome

Who this might be right for
Primary Sjogren's SyndromeLymphoma
Bangdong Gong 6
Testing effectiveness (Phase 2)Study completedNCT03050216
What this trial is testing

QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML

Who this might be right for
Acute Myeloid Leukemia
Masonic Cancer Center, University of Minnesota 8
Not applicableStudy completedNCT00740337
What this trial is testing

Factors That Affect the Development of COPD Symptoms

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Washington University School of Medicine 82
Testing effectiveness (Phase 2)Study completedNCT00394381
What this trial is testing

Autologous Cytokine-induced Killer Cell Adoptive Immunotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome, High Grade
Singapore General Hospital 17
Testing effectiveness (Phase 2)UnknownNCT03439501
What this trial is testing

Avelumab in Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma[AVENT STUDY]

Who this might be right for
Lymphoma, Extranodal NK-T-Cell
Samsung Medical Center 21
Testing effectiveness (Phase 2)Study completedNCT00448201
What this trial is testing

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 71
Not applicableUnknownNCT02732535
What this trial is testing

Natural Killer (NK) Cells Following Bariatric Surgery

Who this might be right for
Natural Killer Cell Deficiency, Familial Isolated
Hadassah Medical Organization 40
Not applicableNot Yet RecruitingNCT07249476
What this trial is testing

Study of NK Cells in the Monitoring of Patients With Acute Leukemia or Myelodysplasia

Who this might be right for
Leukaemia (Acute Myeloid)Leukaemia (Acute Lymphoblastic)Myelodysplastic Syndrome
Nantes University Hospital 55
Next Page